| Literature DB >> 25610790 |
Daniel S Barron1, Peter T Fox2, Heath Pardoe3, Jack Lancaster4, Larry R Price5, Karen Blackmon3, Kristen Berry3, Jose E Cavazos6, Ruben Kuzniecky3, Orrin Devinsky3, Thomas Thesen3.
Abstract
Noninvasive markers of brain function could yield biomarkers in many neurological disorders. Disease models constrained by coordinate-based meta-analysis are likely to increase this yield. Here, we evaluate a thalamic model of temporal lobe epilepsy that we proposed in a coordinate-based meta-analysis and extended in a diffusion tractography study of an independent patient population. Specifically, we evaluated whether thalamic functional connectivity (resting-state fMRI-BOLD) with temporal lobe areas can predict seizure onset laterality, as established with intracranial EEG. Twenty-four lesional and non-lesional temporal lobe epilepsy patients were studied. No significant differences in functional connection strength in patient and control groups were observed with Mann-Whitney Tests (corrected for multiple comparisons). Notwithstanding the lack of group differences, individual patient difference scores (from control mean connection strength) successfully predicted seizure onset zone as shown in ROC curves: discriminant analysis (two-dimensional) predicted seizure onset zone with 85% sensitivity and 91% specificity; logistic regression (four-dimensional) achieved 86% sensitivity and 100% specificity. The strongest markers in both analyses were left thalamo-hippocampal and right thalamo-entorhinal cortex functional connection strength. Thus, this study shows that thalamic functional connections are sensitive and specific markers of seizure onset laterality in individual temporal lobe epilepsy patients. This study also advances an overall strategy for the programmatic development of neuroimaging biomarkers in clinical and genetic populations: a disease model informed by coordinate-based meta-analysis was used to anatomically constrain individual patient analyses.Entities:
Keywords: Biomarker; Epilepsy; Lateralization; Resting-state fMRI; Temporal Lobe Epilepsy; Thalamus; fMRI
Mesh:
Year: 2014 PMID: 25610790 PMCID: PMC4300013 DOI: 10.1016/j.nicl.2014.08.002
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Demographic information.
| Patient | Sex | Handed | Age sz onset | Sz freq. | Wada language | Wada L memory | Wada R memory | GCF | VCI | POI | WMI | PSI |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | R | 17 | 1/m | L | 10 | 10 | Borderline impaired | 77 | 67 | − | − |
| 2 | F | R | 6 | 2–3/m | L | 5 | 11 | Low avg | 96 | 74 | 93 | 91 |
| 3 | F | R | 6 | 3–4/d | L | 3 | 5 | Low avg | 82 | 103 | 88 | 93 |
| 4 | F | R | 32 | 1–2/d | − | − | − | Avg | 98 | 96 | 100 | 102 |
| 5 | F | R | − | − | L | 4 | 11 | Avg | 102 | 105 | 108 | 94 |
| 6 | M | R | − | 1–4/m | L | 10 | 12 | Avg | 107 | 102 | 105 | 108 |
| 7 | F | R | 5 | 2/y | B | 4 | 10 | Low avg | 76 | 80 | 85 | 73 |
| 8 | M | R | 35 | 6 total | B | 12 | 8 | Avg | 107 | 99 | 108 | 91 |
| 9 | F | R | 23 | 1/w | B | 10 | 12 | Superior | 110 | 133 | 111 | 93 |
| 10 | F | R | 29 | 1–2/m | L | 12 | 11 | High avg | 118 | 123 | 127 | 108 |
| 11 | M | R | 5 | 3.5/m | R | 1 | 10 | Borderline impaired | − | − | − | − |
| 12 | F | R | 31 | 2/m | L | 2 | 5 | − | − | − | − | − |
| 13 | F | R | 1 | 1/m | L | 9 | 2 | Avg | − | 95 | − | 81 |
| 14 | M | R | 10 | 1–4/w | L | 5 | 4 | Superior | 150 | 111 | 131 | 122 |
| 15 | M | R | ‘Child’ | 2–3/d | L | 12 | 0 | − | − | − | − | − |
| 16 | F | R | − | 3/m | L | 11 | 5 | Impaired | 72 | 69 | 69 | 62 |
| 17 | M | R | 17 | 1/d | B | 12 | 12 | Avg | 96 | 104 | 86 | 100 |
| 18 | M | R | 21 | 1/m | L | 11 | 11 | Low avg | 75 | − | 86 | 75 |
| 19 | F | R | 7 | 0–2/m | L | 11 | 9 | Avg | 109 | 116 | 91 | 108 |
| 20 | F | R | 28 | 3–4/w | − | − | − | Avg | 125 | 88 | 114 | 89 |
| 21 | M | R | 29 | 2–3/w | L | 12 | 8 | Above avg | 125 | 105 | 128 | 111 |
| 22 | M | R | − | 10–15/m | L | 12 | 0 | Superior | 125 | 128 | − | − |
| 23 | M | R | − | − | L | 10 | 6 | Avg | − | − | − | − |
| 24 | M | R | 14 m | − | − | − | − | Impaired | 76 | 50 | 55 | 76 |
R = right.
Self-reported, m = month, w = week, d = day.
General cognitive function.
Verbal comprehension index.
Personal orientation inventory.
Working memory inventory.
Psychological screening.
Classification of laterality and corresponding clinical information.
| Patient | Laterality classification | HS | Lesion | iEEG? | Sz onset | Resection location | Engel outcome |
|---|---|---|---|---|---|---|---|
| 1 | Left | L | L MTS | Y | L MT | L AT, HPC | Engel 1 |
| 2 | Left | L | L MTS | N | L T (vEEG) | N/A | N/A |
| 3 | Left | L | L MTS | Y | L MT | L AT, HPC | Engel 4 |
| 4 | Left | L | L MTS | N | L T (vEEG) | N/A | N/A |
| 5 | Left | L | L HPC infarct | Y | L MT | L AT, HPC | Engel 1 |
| 6 | Left | L | No | Y | L MT & middle TL | L Inferior AT | Engel 1 |
| 7 | Left | B | No | Y | L MT | L AT, HPC | Engel 1 |
| 8 | Left | No | Y | L MT | L AT, HPC | Engel 2 | |
| 9 | Left | No | Y | L MT | L AT, HPC | Engel 1 | |
| 10 | Left | L HPC & BT dysgenesis | N | L T & F (vEEG) | N/A | N/A | |
| 11 | Left | L MTS | Y | L MT | L AT, HPC, AMY | Engel 1 | |
| 12 | Left | L T cyst | Y | L MT | L AT, HPC | Engel 1 | |
| 13 | Right | R | No | Y | R MT | R AT | Engel 1 |
| 14 | Right | R | T gliosis | Y | R MT & R O | R AT & R O | Engel 1 |
| 15 | Right | R | R MTS | Y | R MT | R AT, HPC, AMY | Engel 3 |
| 16 | Right | R | R MTS | Y | R MT & mid T | R AT, HPC, AMY | Engel 2 |
| 17 | Right | R | R MTS | Y | R MT | R AT, HPC, AMY | Engel 1 |
| 18 | Right | B | CC & parietal hypoplasia | Y | R MT | R AT, HPC | Engel 1 |
| 19 | Right | R Parietal-occipital cystic lesion | Y | R MT, R mesial O | R AT, R mesial O, & HPC | Engel 1 | |
| 20 | Right | R MTS | N | RT & F (vEEG) | N/A | N/A | |
| 21 | Right | R PT cavernoma | Y | R MT & PT | R AT & PT cavernoma | Engel 2 | |
| 22 | Right | R MTS | Y | R MT, AT, & mid T | R AT, HPC | Engel 1 | |
| 23 | Right | No | Y | R MT | R AT, HPC, AMY | Engel 3 | |
| 24 | Right | No | Y | R TL & MF | No resection | N/A |
Abbreviations: MTS = medial temporal sclerosis, T = temporal, O = occipital, F = frontal, AT = anterior temporal, PT = posterior temporal, M = mesial, HPC = hippocampus, AMY = amygdala, BT = basal temporal, CC = corpus callosum.
Classification of laterality established by iEEG and vEEG and used in connectivity analysis.
Significantly lower hippocampal volumes compared to control population.
Lesions identified by radiologist's visual inspection of MRI.
Localization of seizure onset established by iEEG or when unavailable, vEEG as indicated.
Fig. 1Analysis overview. Individual subject structural MRI image volumes were segmented and the thalamus, hippocampus, amygdala, and entorhinal cortex volumes of interest (VOIs) were transformed to functional MRI space. Within these VOIs, mean time series were extracted and cross correlations were computed. 1) Group comparisons were performed with Mann–Whitney tests. 2) The effect size of individual patient's TLE on rho was compared to corresponding mean of healthy controls (n = 20). 3) Discriminant analysis and 4) logistic regression were performed to predict seizure onset laterality from functional connectivity effect size. Selection of effect size predictors is described in eMethods and supplementary materials.
Summary of discriminant and logistic regression analyses.
| Patient number | HS | Actual group 0 = L;1 = R | Discriminant analysis (2 predictors | Logistic regression (4 predictors | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No bootstrap | Bootstrap (n = 1000) | No bootstrap | Bootstrap (n = 1000) | |||||||||||
| Original | Cross-validation | Original | Cross-validation | |||||||||||
| Group | P (p = 1) | Group | P (p = 1) | Group | P (p = 1) | Group | P (p = 1) | Group | P (p = 1) | Group | P (p = 1) | |||
| 1 | L | 0 | 0 | 0.10 | 0 | 0.11 | 0 | 0.10 | 0 | 0.11 | 0 | .094 | 0 | .094 |
| 2 | L | 0 | 0 | 0.44 | 0 | 0.49 | 0 | 0.44 | 0 | 0.49 | 0 | .115 | 0 | .115 |
| 3 | L | 0 | 0 | 0.09 | 0 | 0.10 | 0 | 0.09 | 0 | 0.10 | 0 | .267 | 0 | .267 |
| 4 | L | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | .000 | 0 | .000 |
| 5 | L | 0 | 0 | 0.11 | 0 | 0.12 | 0 | 0.11 | 0 | 0.12 | 0 | .216 | 0 | .216 |
| 6 | L | 0 | 0 | 0.03 | 0 | 0.04 | 0 | 0.03 | 0 | 0.04 | 0 | .009 | 0 | .009 |
| 7 | B | 0 | 0 | 0.06 | 0 | 0.07 | 0 | 0.06 | 0 | 0.07 | 0 | .080 | 0 | .080 |
| 8 | 0 | 1** | 0.62 | 1** | 0.67 | 1** | 0.62 | 1** | 0.67 | 0 | .475 | 0 | .475 | |
| 9 | 0 | 0 | 0.02 | 0 | 0.02 | 0 | 0.02 | 0 | 0.02 | 0 | .029 | 0 | .029 | |
| 10 | 0 | 0 | 0.03 | 0 | 0.04 | 0 | 0.03 | 0 | 0.04 | 0 | .016 | 0 | .016 | |
| 11 | 0 | 0 | 0.31 | 0 | 0.33 | 0 | 0.31 | 0 | 0.33 | 0 | .378 | 0 | .378 | |
| 12 | 0 | 0 | 0.04 | 0 | 0.04 | 0 | 0.04 | 0 | 0.04 | 0 | .035 | 0 | .035 | |
| 13 | R | 1 | 1 | 0.66 | 0** | 0.17 | 1 | 0.66 | 0** | 0.17 | 1 | .975 | 1 | .975 |
| 14 | R | 1 | 1 | 0.90 | 1 | 0.89 | 1 | 0.90 | 1 | 0.89 | 1 | .996 | 1 | .996 |
| 15 | R | 1 | 1 | 0.66 | 1 | 0.64 | 1 | 0.66 | 1 | 0.64 | 1 | .898 | 1 | .898 |
| 16 | R | 1 | 1 | 0.94 | 1 | 0.93 | 1 | 0.94 | 1 | 0.93 | 1 | .982 | 1 | .982 |
| 17 | R | 1 | 1 | 1.00 | 1 | 1.00 | 1 | 1.00 | 1 | 1.00 | 1 | .999 | 1 | .999 |
| 18 | B | 1 | 0** | 0.17 | 0** | 0.08 | 0** | 0.17 | 0** | 0.08 | 0** | .091 | 0** | .091 |
| 19 | 1 | 0** | 0.21 | 0** | 0.13 | 0** | 0.21 | 0** | 0.13 | 0** | .394 | 0** | .394 | |
| 20 | 1 | 1 | 0.96 | 1 | 0.96 | 1 | 0.96 | 1 | 0.96 | 1 | .984 | 1 | .984 | |
| 21 | 1 | 1 | 0.95 | 1 | 0.94 | 1 | 0.95 | 1 | 0.94 | 1 | .968 | 1 | .968 | |
| 22 | 1 | 1 | 0.99 | 1 | 0.99 | 1 | 0.99 | 1 | 0.99 | 1 | 1.000 | 1 | 1.000 | |
| 23 | 1 | 1 | 0.97 | 1 | 0.97 | 1 | 0.97 | 1 | 0.97 | 1 | .998 | 1 | .998 | |
| 24 | 1 | 1 | 1.00 | 1 | 1.00 | 1 | 1.00 | 1 | 1.00 | 1 | 1.000 | 1 | 1.000 | |
Hippocampal sclerosis determined by volumetric analysis, see eMethods, L = left, R = right, B = bilateral.
2 predictors = individual differences in connectivity between left thalamus and left hippocampus and between right thalamus and right entorhinal cortex.
4 predictors = individual differences in connectivity between left thalamus and left hippocampus, between right thalamus and right entorhinal cortex, between left amygdala and left amygdala, and between right posterior hippocampus and left anterior hippocampus.
PPV = positive predictive value, NPV = negative predictive value, both PPV and NPV were calculated based on our sample population.
Fig. 2Effect size of TLE laterality on functional connectivity. Left: effect size was calculated as the difference of group averaged Fischer transformed correlation coefficients for R (red) and L (blue) TLE patients subtracted from the control group mean (Cohen, 1988). Effect sizes used as predictors for discriminant analysis are denoted with * and those used for logistic regression denoted with both * and **. To improve clarity of the figure, the redundant upper triangle of the matrix has been excluded. Right: diagram of effect sizes used to predict seizure onset laterality. Red lines represent increased functional connectivity compared to control; blue lines represent decreased. Triple lines represent effect sizes used in discriminant analysis; logistic regression used both triple and single lines.
Fig. 3ROC curve of discriminant and logistic regression analysis methods. Curve is based on individual patient data reported in Table 3. Discriminant analysis probabilities were adjusted to be relative to diagnosis of RTLE, P (p = 1).